TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,271,216 | -86.5% | 254,051 | -76.9% | 0.01% | -87.9% |
| Q2 2023 | $16,865,971 | -54.8% | 1,098,045 | -33.8% | 0.06% | -56.1% |
| Q1 2023 | $37,303,916 | +204394.7% | 1,658,689 | +91.2% | 0.13% | +100.0% |
| Q4 2022 | $18,242 | -99.9% | 867,419 | -6.2% | 0.07% | -24.1% |
| Q3 2022 | $22,780,000 | -1.1% | 924,514 | -2.7% | 0.09% | +2.4% |
| Q2 2022 | $23,030,000 | +187.0% | 950,465 | +205.3% | 0.08% | +286.4% |
| Q1 2022 | $8,024,000 | +32.2% | 311,351 | +59.2% | 0.02% | +22.2% |
| Q4 2021 | $6,069,000 | – | 195,531 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 411,680 | $10,609,000 | 9.85% |
| VR Adviser, LLC | 1,994,997 | $51,411,000 | 8.33% |
| Kynam Capital Management, LP | 870,918 | $22,444,000 | 7.28% |
| GREAT POINT PARTNERS LLC | 1,010,000 | $26,028,000 | 6.29% |
| Deep Track Capital, LP | 3,134,503 | $80,776,000 | 5.18% |
| RA Capital Management | 4,922,941 | $126,864,000 | 2.77% |
| ARMISTICE CAPITAL, LLC | 4,958,000 | $127,768,000 | 2.47% |
| MPM BioImpact LLC | 277,950 | $7,163,000 | 1.92% |
| Sofinnova Investments, Inc. | 658,249 | $16,963,000 | 1.29% |
| Perceptive Advisors | 1,845,555 | $47,560,000 | 0.95% |